| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP, Finance | CFO &Executive Vice President +1 more
5 companies
Sharp Shalini serves as a Director at AGEN and has filed Form 4s across 5 companies. Across recent SEC filings that breaks down to 0 buys and 43 sells. Those positions are worth an estimated $9.1M at current prices.
The biggest single holding is RARE (~$8.6M) as EVP, Finance. The recent filings there lean toward selling, a net 201,572 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 18, 2015 | RARE Ultragenyx Pharmaceutical Inc. | CFO &Senior Vice President | Sell | 4,000 | $53.98 | $215,935.48 | -6.6% | |
| Jan 20, 2015 | RARE Ultragenyx Pharmaceutical Inc. | CFO &Senior Vice President | Sell | 4,000 | $51.24 | $204,957.20 | -6.2% |